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ABSTRACT 
Warnakula, Indika K., Long-Term Storage Stability and Oxidation Products of the 
Cyanide Antidote Dimethyl Trisulfide. Master of Science (Chemistry), August, 2018, Sam 
Houston State University, Huntsville, Texas. 
 
Exposure to cyanide (CN) leads to the malfunction of mitochondrial activity by 
inhibiting the terminal oxidase, cytochrome c oxidase. The brain and heart are the highest 
oxygen consumers and are the critical target organs harmed by CN. Dimethyl trisulfide 
(DMTS) is a well-studied CN antidote with the major mechanism of sulfur donation for 
CN conversion to SCN. However, recent investigations revealed a minor mechanism of 
methemoglobin formation from DMTS that is a CN scavenger type antidote. Formulation 
efforts of DMTS focus on optimizing pharmacokinetic and storage stability parameters. 
This study reports the storage stability of a formulation for DMTS (F3-formulation) 
developed by Southwest Research Institute, San Antonio, Texas. The F3-formulated 
DMTS was stored in glass ampules at 4, 22 and 37 ºC. At regular time intervals over the 
period of one year, nine ampules (three stored at each temperature) were opened and 
analyzed by HPLC-UV to determine their DMTS content. The results showed that there 
was no measurable loss of DMTS over the one-year period of the study for the samples 
stored at 4 and 22 ºC. The samples stored at 37 ºC showed good stability for five months. 
However, in the sixth month of storage, these samples showed a 10% (M/M) decrease in 
DMTS content. Discoloration and the appearance of a new peak in the HPLC 
chromatogram accompanied this loss of DMTS. Continued growth of these new peaks and 
deepening discoloration was observed over the final 5 months of the study. To identify the 
degradation products formed during storage at 37 ºC, separate oxidation studies were 
performed with DMTS using strong oxidizing agents, such as mCPBA or H2O2. The 
products of the oxidation studies were compared to those of the stability study samples. 
Dimethyl tetrasulfide and dimethyl pentasulfide were observed as products of both studies. 
Dimethyl disulfide was observed as a product of degradation and S-methyl 
methanethiosulfonate was revealed as a product of oxidation. The HPLC and GC-MS 
SPME analysis revealed a good agreement between the degradation products of the 
stability study and the direct oxidation reactions.  Because the 22 and 4 ºC samples 
remained stable for a year, we can conclude that the F3-formulated DMTS fulfills the 
criteria for storage stability. 
v 
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Sources and Toxicity of Cyanide 
Cyanide Sources  
The word “cyanide” (CN) originated from the Greek word kyanos meaning dark 
blue. CN can be found everywhere in the cosmos and in various spheres of nature. CN 
sources can be natural or man made. The natural CN sources are cassava root, yams, maize, 
bitter almonds, apricot, apple and peach seeds, where CN is present as cyanoglucosides.1 
Other than that, lightning and volcanic eruption can easily form CN in the environment.2 
Some fungi, bacteria and animals produce CN for self-defense purposes. CN is present in 
smoke from: cigarette, and fires (fueled by nitrogen containing molecules, acrylonitrile, 
wool, silk).3 CN is used in the electroplating industry,4 gold and silver extraction industry,5 
and in the battery the industry.6 Hydrogen cyanide, the acidic form of CN, was first isolated 
from cherry laurel by a Swedish chemist, Carl Wilhelm Scheele, in 1782.7 Since it appears 
as white crystals, many have misidentified it as white sugar or salt.8 The basic form of CN 
is the cyanide anion, CN-. It has a molecular weight of 26.018 g/mol and has a formal a 
charge of -1 which is a supportive for complexation.9 In ancient Egypt, CN was used as 
one of the toxic compounds for judicial executions (they have identified  high content of 
CN in peach seeds),10 and also as an additive of a gold containing drug developed in ancient 
Chinese experiments.11 Very recently CN was used as a warfare agent: HCN gas was used 
in World War II by the Nazis against the innocent holocaust12 victims and by the Liberation 
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Tigers of Tamil Eelam (LTTE) terrorist group as a suicidal agent to be taken by members 
who were captured by the Sri Lankan government army.13  
 
Toxicity of CN  
CN is a very toxic agent, which inhibits the cellular oxygen utilization of living 
beings. The possible toxicity may occur through inhalation of smoke from industrial or 
residential activities, oral administration through food and drinks and dermal absorption 
threat attack.14,15 Exposure to CN through one of these routes may cause severe illness or 
death. CN enters into the mitochondria of the living cell and binds to the terminal enzyme 
of the electron transport chain cytochrome c oxidase, resulting in acute cellular hypoxia, 
which prevents the production of ATP inside the cell.16 Due to these actions, the anaerobic 
pathway becomes dominant, and promotes the reduction of pyruvate to lactic acid resulting 
in lactic acidosis. This leads to central nervous system and myocardial depression.3 CN can 
be present in the molecular form of hydrogen cyanide (HCN) and in the anion CN-. The 
ratio of HCN:CN- forms of CN in the human body is approximately 63.1. The pKa of HCN 
is 9.2. HCN can easily penetrate through the cellular and subcellular membranes.3 High 
doses of CN (~LD50) are able to produce more critical symptoms such as induction of 
pulmonary arteriolar and coronary vasoconstriction, which can cause pulmonary edema or 
cardiogenic shock. The lower doses of CN result in dizziness, headache, vomiting and 





Antidotes for CN Intoxication 
Different Types of CN Antidotes 
Several types of CN antidotes were identified after many years of research. The two 
identified mechanisms of action to treat CN intoxication are the use of scavengers and 
detoxification agents. 
Scavengers  
This type of antidote can form stable complexes with CN, such as methemoglobin 
or cobalt compounds. Amyl nitrite, sodium nitrite and 4-dimethylaminophenol are 
examples of methemoglobin formers (Figure 1). 
 
Figure 1. Conversion of Hemoglobin to Methemoglobin by Nitrite Anion.  
 
 
In the US, the currently available major CN antidotes are the NithiodoteTM and the 
Cyanokit®. NithiodoteTM, is a scavenger type antidote that contains a combination of 
sodium nitrite and sodium thiosulfate (TS). Nitrous acid has a pKa of 3.15 and present in 








methemoglobin by changing the oxidation state of the heme center from Fe2+ to Fe3+ 
(Figure 2). Methemoglobin has the ability to trap the CN- anion in its heme center and to 
form cyanomethemoglobin. Rhodanese (Rh) converts CN to the less toxic thiocyanate 
(Figure 3) with TS and is excreted form the body with urine. 
 
𝐹𝑒(𝑎𝑞)
2+ + 𝑁𝑂2 (𝑎𝑞)
− + 2𝐻(𝑎𝑞)
+                                       𝐹𝑒(𝑎𝑞)
3+ + 𝐻2𝑂(𝑙) + 𝑁𝑂(𝑔) 
 





−                                       𝑆𝐶𝑁(𝑎𝑞)
− + 𝑆𝑂3 (𝑎𝑞)
2−  
 
Figure 3. Conversion of the Toxic CN into the Less Toxic SCN in the Presence of Rh.  
 
 
Cyanokit® contains hydroxocobalamin as the active agent. Hydroxocobalamin can 
bind CN- to its Co2+ containing metal center and convert it to cyanocobalamin (Figure 4). 
With this process, the body easily removes CN and reduces its toxic effect.  
Both of these antidotes have the limitation that they require intravenous (IV) 
administration, which is impractical when treating elevated number of victims. In addition, 
TS has low sulfur donor efficacy, which is unfavorable to CN conversion to SCN-. The 
presence of endogenous Rh enzyme catalyzes the conversion of CN to SCN and TS. 
Excessive use of nitrite may lead to the production of excess methemoglobin, which causes 
methemoglobinemia resulting in the reduction of oxygen transportation. Cyanokit® needs 
in situ preparation and high injection volumes (>200 mL).17 Due to the identified 
drawbacks, scientists studied the sulfur containing molecules which can donate “S” easily. 
The journey of investigating new CN antidotes resulted in three new types of antidotes: a) 




hydroxocobalamin), and c) sulfanegen (successor of the mercaptopyruvate).18,19 Figure 5 
shows the mechanism of sulfur donation. 
 












Detoxifiers are molecules that convert CN into the less toxic SCN or into a different 
component, which is easily excreted from the body. The recently understood detoxifiers 
are TS, sulfanegen, 3-mercaptopyruate (3-MP), cystine and α-ketoglutarate (α-KG).20–22 
Rh and 3-mercaptopyruate sulfurtransferase enzymes catalyze the CN conversion to SCN 
in the presence of a sulfur donor. Here both TS and 3-MP act as sulfur donors. Cystine acts 
as another detoxifier, which removes CN from the medium by producing 2-amino-2-





mechanisms, there is an alternative detoxification process, in which CN reacts with α-KG. 
Here the formation of α-ketoglutarate cyanohydrin eliminates CN. α-KG is found in all 
aerobic organisms. Reactions of CN with detoxifiers have been summarized below (Figure 
6).21  
 
Figure 6. CN Detoxification Pathways. Based on Mitchell et al.21 
 
 
Another recently discovered detoxifier molecule is DMTS which acts as a sulfur 
donor. This molecule also has the ability to convert hemoglobin into methemoglobin, 
which is considered as a scavenger.17,23 
 
Dimethyl Trisulfide (DMTS) 
DMTS is used as a flavor enhancer and food additive in the food industry. It is 
produced in fungating cancer wounds.24 DMTS is also present in many natural sources 
such as broccoli, cabbage, cauliflower, onion and in the highest concentration in garlic. In 






catalyzed by the alliinase enzyme. One of these products is allicin, which can be extracted 
with ethanol and gives the characteristic garlic odor. The majority of decomposition 
products are soluble in fats, oils and non-polar solvents, but insoluble in water which is 
polar.17 Alliin also undergoes different reactions to produce various di- and polysulfide 
compounds. Sulfur containing compounds in garlic, such as DMTS and diallyl disulfides, 
have been studied as sulfur donating compounds which can be used as CN antidotes (Figure 
7).25 Several sulfur donor type molecules have been tested and the garlic component DMTS 
proved to be the best CN antidote.  The application of DMTS and its formulation as a CN 
antidotes patented by Dr. Petrikovics’s lab (Sam Houston State University, Huntsville, 
Texas) under the title of CN antidote compositions (US 20150290143 A1, 2015; US 
20150297535 A1, 2015).26,27 Unlike TS, DMTS can convert CN to SCN with high 
efficiency with and without Rh, and has a higher antidotal potential than TS in the same 
dose. The intramuscular (IM) administration makes formulated DMTS superior over 
Nithiodote™ and Cyanokit® as victims can self-administer the antidote during CN 
exposure.  
  
Figure 7. Structure of DMTS.28 
 
Formulated DMTS   
Literature data showed that DMTS has higher efficiency compared to TS to donate 
a sulfur atom to CN.23 The middle sulfur atom of DMTS is the one proposed to, which 
binds to CN. The next step was to develop formulations for IM administration and to 
characterize the formulations in vitro and in vivo. Micelles can provide a suitable carrier 
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system for the lipophilic DMTS to penetrate the blood brain barrier with the help of their 
hydrophilic corona although their core is hydrophobic.15 The goal of the development of 
formulations for DMTS is to achieve a set of characteristics such as suitability for IM, 
increased solubility, improved stability in vivo and in vitro, improved in vivo antidotal 
efficacy, enhanced bioavailability and improved absorption kinetics. Development of 
formulations can be achieved using three different criteria such as solvent combinations, 
co-solvents and surfactants. One of the DMTS formulations developed by Dr. Petrikovics’s 
lab is 15% (m/v) polyoxyethylenesorbitan monooleate 80 (poly 80). There are three 
different types of DMTS-related formulations used in Dr. Petrikovics’s lab. These 
formulations are labelled as F1, F2 and F3 according to their used chronological order. 
 F1-Formulaton : Lipid-Based Formulation (micellar or liposomal 
encapsulation) 
 F2-Formulation   : 15% (m/v) poly 80 in ethanol (EtOH) – (patented at Sam 
Houston State University, Huntsville, Texas) 
 F3-Formulation : poly 80 : sorbitan monooleate (span 80) (3:1) – 
(developed at Southwest Research Institute - SwRI, San Antonio, Texas) 
After developing an efficient DMTS formulation, it needed to be characterized for 
future use. Stability, size distribution, in vivo efficacy, pharmacokinetics, blood-brain 
barrier penetration and organ distribution experiments are examples for some of the 
characterization experiments. The major focus of this thesis project was the investigation 





Lipid-Based Formulated DMTS  
One of the earliest approaches was the development of the lipid-based formulation. 
This formulation was developed based on using of co-polymer PEG2000-DSPE. The 
preparation of the formulation had five consecutive steps, Step 1: preparation of PEG2000-
DSPE stock solution in EtOH. Step 2: formation of the lipid film. Step 3: rehydration of 
the lipid film to target concentration. Step 4: addition of DMTS. Step 5: vortexing at 50 ºC 
for 20 minutes. The concentration of DMTS in this formulation was found to be 2.5 
mg/mL. Instability and low encapsulation efficiency of this lipid-based formulation led to 
further investigations on new formulations.15,29  
15% Poly 80 Formulated DMTS  
This formulation was prepared by mixing pure DMTS with 15% (m/v) aqueous 
poly 80 solution. The solubility of DMTS in water is only 0.13 mg/mL,25,30 therefore it was 
necessary to enhance this feature. The surfactant poly 80 helped to dissolve DMTS in water 
up to 86 mg/mL concentration.30,31 Former member of Dr. Petrikovics’s research group Dr. 
Lorand Kiss compared the storage stability of the 15% (m/v) poly 80 formulated DMTS in 
snap-cap and crimp-sealed vials versus ampules. DMTS in EtOH was stable for few hours. 
Reduction of 36%-58% (M/M) in DMTS content in 15% (m/v) poly 80 formulation stored 
in snap-cap and crimp-sealed vials within a 29-week period was previously reported.25  
Because of the low stability in snap-cap and crimp-sealed vials, hermetically fire-
sealed ampules were used for the storage of the formulated DMTS. The study has reported 
that the F2-formulated DMTS in hermetically fire-sealed vials was stable for 100 days. 
This suggested the suitability of hermetically fire-sealed vials for the storage of F3-
formulated DMTS.30 The maximum concentration of DMTS in the F2-formulation was 
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reported as ~86 mg/mL.32 The identified disadvantage of this formulation is its 
impracticality for applications in mass scenarios, since it needs high injection volumes. 
Therefore, the development of more suitable formulations with higher antidote 
concentrations were conducted. 
Poly 80 : Span 80 (3:1) Formulated DMTS  
This formulation was developed in Southwest Research Institute, San Antonio, 
Texas. The initial goal of this new formula is to overcome the low stability of F1 and the 
high injection volume requirement of F2. This formulation was prepared using poly 80 and 
span 80 in a ratio of 3:1 (m/m). The ratio of DMTS is 40% (m/m) in the formulation. 
Therefore, the requirement for a low injection volume can be fulfilled with this 
formulation. The F3-formulation still needs to be characterized before future use. Recent 
studies found its slower absorption rate as one of the disadvantages. There were several 
studies carried out for the characterization of the F3-formulation, their results will be 
published in the near future. 
 
Redox Reactions with DMTS 
It was reported that dialkyl polysufides undergo disproportionation reactions.33 The 
reaction rate of disproportionation depends on the temperature, it is specially faster at high 
temperatures such as above 145 – 160 ºC.33 The thermally decomposed products are also 
unstable and they undergo further decomposition. According to the results, 
disproportionation of DMTS could produce dimethyl sulfide (DMS), dimethyl disulfide 
(DMDS), dimethyl tetrasulfide (DM4S) and dimethyl pentasulfide (DM5S). There is a 
possibility of dimethyl hexasulfide to occur also, but the higher the number of sulfur atoms 
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in the sulfur chain the lower the bonding energy. Primarily, symmetrical cleavage of the 
sulfur chain was observed in the majority of the cases, while asymmetrical cleavage was 
secondary.  Generation of elemental sulfur was also observed during those studies.33 
Through reduction reactions, thiols and hydrogen sulfide were formed, while the 
release of sulfur atom radicals from polysulfides were reported.34,35 When oxidation 
reactions took place, thiosulfate and thiosulfonate were formed from the organic 
polysulfides.36 Certain studies reported the production of dimethyl thiosulfinate also 
(Figure 8). The DMTS molecule was oxidized by 30% hydrogen peroxide (H2O2) in the 
presence of HNO3. Some of the literature have brought up oxidation of all three sulfur 
atoms, two sulfur atom and one sulfur atom in DMTS, and oxidation of terminal sulfur 
atom. It is possible that along with the disproportionation, an oxidation reaction occurred 
due to the small amount of air within the hermetically fire-sealed glass ampules.16,37,38 
According to the literature, the following reactions could occur with DMTS (Figure 
8). 
 













Gas Chromatography - Mass Spectrometry (GC-MS)   
GC-MS is a combined instrumental technique, which allows separation, 
quantification and identification of components of complex solution mixtures. This is one 
of the well-known and common methods for identification of molecules of complex 
mixture. GC can separate molecules from each other based on their polarity and affinity to 
the column stationary phase. For example, if the stationary phase is non-polar, the non-
polar components will be retaining longer and the polar components elute with the mobile 
phase sooner. The ion source in the MS breaks the molecules into fragments by ionizing 
them and later they can be separated depending on their mass-to-charge ratios (m/z). Based 
on the amount of similar molecules or fragments of the components, the area under the 
curve for quantification purposes can be determined. The important components of GC-
MS will be explained below (Figure 9).39  
The high purity gas source is one of the important requirements. Usually these gases 
are prepurified, although the instrument passes them through a filter system for safety and 
quality reasons. It is important to maintain the required pressure and flow of the gas for 
analysis. Therefore, the gas supply is controlled with a pressure regulator. Several different 
types of gases are used in GC depending on the detector: the carrier gas can be either H2, 
He or N2.
40,41  
There are sets of pneumatic controls in the GC depending on the type of analysis 
and the type of detector. GC uses a split/splitless inlet and it requires the maintenance of 
the carrier gas supply pressure, column inlet pressure, inlet septum purge flow and inlet 
split flow. Basically, all the operations of the GC-MS instrument are maintained through 
13 
 
pneumatic controls. Most of the modern instruments are coupled with a PC for electronic 
control and for ease of use, although older instruments may have manual pressure control 
via regulators.40,42 
The samples usually inject to the column through inlet. Usually, the temperature in 
the inlet is higher than in the oven. The sample can easily evaporate and enter to the carrier 
gas (mobile phase). In the lab we use split/splitless inlet.  
The retention of analytes depends on the interactions with the column. This is 
similar to HPLC or TLC. Interactions between the stationary phase and compound are 
important for analysis. There are three bonding categories depending on interaction type: 
hydrogen bonding, dipole and dispersive. The analyte mixtures are separated into groups 
on the column. The columns divide into two main types: they can be capillary or packed. 
That varies with application type and the affects length and internal diameter. Capillary 
columns are long hollow silica pipes. Their wall is covered with the stationary phase on 
the inside. Many different stationary phases are available for different applications. 
The oven contains the GC column. This oven can be heated or cooled. This 
difference in temperature helps to separate compounds. The sample enters onto the column 
from the inlet through the injector connection and exits through MS interface. We use a 
temperature program during the analysis to separate the products of the stability study and 
the oxidation reaction.40   
The detector responds to a physicochemical property of the analyte. After 
amplification, an electronic signal is generated. Based on that the computer draws the 
chromatogram. The software can use this information for qualitative and quantitative 
14 
 
analysis also. One can select the detector type based on application and sensitivity. In the 
lab, we use the mass spectrometer as the detector.39,40  
 
Figure 9. Schematic Diagram of a GC-MS Instrument.  
 
 
High Performance Liquid Chromatography (HPLC)   
HPLC is an improved form of liquid chromatography. The mobile phase is forced 
through the column at pressures as high as 420 atmospheres. This is a fast process 
compared to gravitational liquid chromatography. All chromatographic separations are 
based on the same principle. Separation of the components of the mixture is based on their 
affinity to stationary phase and the mobile phase. There are several types of HPLC, which 
are listed below.39,43,44 Normal phase-, reverse phase-, adsorption-, ion-, and size exclusion 
chromatography are the examples for the type of HPLC. We used a reverse phased column 
(C8) during our experiments. As shown in the schematic diagram (Figure 10) the HPLC 
instrumentation includes major components of solvent reservoir, high pressure pump, 
sample injector, column, detector and data acquisition and display system. The heart of the 













Figure 10. Schematic Diagram of the HPLC Instrument.  
 
 
The mobile phases are placed in glass bottles. They are usually a mixture of polar 
and non-polar liquid components. The pump forces the mobile phase from the solvent 
bottles through the column and the detector. The flow rate depends on the dimensions of 
the columns, the stationary phase particle size and the composition of the mobile phase.  
The injector can be manual or automated. It should provide injection of the liquid 
sample within the range of volume 0.1-100 µL. Columns are made of stainless steel with 
an internal diameter of between 2 and 20 mm. They are filled with a stationary phase where 
the particle size is between 3–10 µm. Unlike in GC-MS the temperature of the HPLC 
column is kept constant. The detector reveals the analytes in the order of elution. Our HPLC 
is equipped with UV/Vis and fluorescence detectors. Signals from the detector are collected 














Thin Layer Chromatography (TLC)   
In the TLC, a solid phase is coated onto a solid support as a thin layer. During the 
experiments, we used aluminum sheets as solid support. The mixture of components is 
dissolved and the solution is spotted near the bottom of the thin layer plate. They are left 
to dry for a few minutes. Based on the capillary effect, the eluent is flowing from the bottom 
to the top. If the eluent is non-polar the non-polar components in the mixture travel faster. 
However, the eluent is polar, the polar components of the mixture will travel faster 
according to the normal phase stationary phase.  After drying the plate we used UV-light 


















MATERIALS AND METHODS 
Chemicals 
All the chemicals used were commercially available. DMTS, DMDS, calcium 
carbonate, calcium bicarbonate, hexane (C6H14), ethyl acetate (EtOAc), H2O2, acetone and 
EtOH were purchased from Sigma-Aldrich (Milwaukee, WI, USA), S-methyl 
methanethiosulfonate (SMMTS) was purchased from Sigma-Aldrich (St. Louis, MO, 
USA), meta-chloroperbenzoic acid (mCPBA), acetonitrile and water (HPLC-grade) was 
purchased from Acros Organics (Thermo Fisher Scientific, Waltham, MA USA). Poly 80 
was from Alfa Aesar (Tewksbury, MA, USA), and Span 80 was purchased from TCI 
(Toshima, Kita-Ku, Tokyo, Japan).  
 
Instruments 
Table 1 lists the instruments used in these experiments. 
Table 1 
Analytical Instruments Used in this Research. 
Instrument Brand and Model Location 
HPLC Thermo Scientific Dionex Ultimate 3000 1 
GC-MS Agilent Technologies 7890A GC System and 5975C VL 
MSD 
1 
Ampoule Sealer Unbranded RF-1 Ampoule bottle sealing machine 201698 1 
Analytical Scale Mettler Toledo New Classic MF ML204/03 1 
pH meter Thermo Scientific Orion Star A111 1 
Centrifuge VWR International Galaxy 20R 1 
Auto Vortex Heidolph Multi Reax 1 
TLC Plate Agela Technologies, T-CSF200200-A  1 
SPME Holder Supelco Analytical, 57330-U Manual 1 
SPME Fiber Agilent Technologies SPME Fiber Assembly 391896301 1 
UV-light UVP LLC, UL Listed Insp. & Meas. EQ 399-J UVGL-25 2 





Preparation of the F3-Formulated DMTS Solution for the Long-Term 
Storage Stability Study  
This formulation was prepared according to the protocol provided by the Southwest 
Research Institute (SwRI), San Antonio, Texas. It contains poly 80 and span 80, without 
any water. An amount of 99.57 g of poly 80 and 33.20 g of span 80 were weighed into a 
10 ml glass bottle and hand vortexed for 5 minutes, then DMTS (88.5 g) was added to 
prepare 221 g of stock solution. The resulting mixture was hand-vortexed (VWR Fixed 
Speed Mini Vortex) for further 5 minutes, followed by auto-vortexing (2000 RPM speed) 
(Heidolph Multi Relax Auto-vortex) for 30 minutes. This gave a clear, yellowish solution.  
 
Storage of F3-formulated DMTS  
The prepared F3-formulated DMTS was transferred into glass ampules. A total 
number of 189 glass ampules were used. Each glass ampule (2.0 mL) was filled with 1 mL 
of F3-formulated DMTS and sealed using an ampule sealer (Figure 12). Before fire-
sealing, each glass ampule was examined to ensure it did not have formulated DMTS on 
the wall of the neck of the ampule.  







The sealed glass ampules were separated into 3 groups and were color coded with 
blue (4 ºC), yellow (22 ºC) and red (37 ºC) tape. When storing the fire-sealed glass ampules 
the following scheme was applied (Figure 13). 
 




The glass ampules were examined for proper sealing and defective fire-sealed 
ampules were removed from the quota. The grouped fire-sealed glass ampules were 
transferred to plastic ampule holders and stored in a fridge, in a cabinet, or in an oven 
(Figure 14). The temperatures were monitored at each sampling point to keep track of the 
temperature fluctuations. 
 
Figure 14. Room Temperature (22 °C) Stored, Ampule-Sealed, F3-formulated DMTS.  
F3-formulated DMTS (200 ml) 
63 ampules stored at 37 ºC 63 ampules stored at 22 ºC 63 ampules stored at 4 ºC
Sealed into 189 glass ampules
(1 mL per each vial)
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The stored DMTS containing glass ampules were analyzed according to the 
sampling point of 0 to 6 days, 1 to 3 weeks and 1 to 12 months. 
 
Analytical Method Development for the Measurement of DMTS content in the 
F3-formulated DMTS by HPLC-UV/Vis  
A method to analyze DMTS in blood by HPLC-UV was published earlier by Dr. 
Petrikovics’s lab.19 This method was modified to analyze the low DMTS concentration 
levels in aqueous medium of the parallel artificial membrane permeability assay samples.  
Preparation of a calibration curve for the analysis of the F3-formulated DMTS  
F3-formulated DMTS (400 mg/mL DMTS) was diluted in two steps with EtOH to 
obtain a working solution of 0.05 mg/mL DMTS. All the solutions were prepared in glass 
vials and micropipettes with plastic tips were used for solutions transfers. The stock F3-
formulated DMTS (50 µL) was diluted with EtOH (4950 µL) to obtain 4 mg/mL solution. 
First diluted solution (62.5 µL) was diluted with EtOH (4937.5 µL) to obtain 0.05 mg/mL 
solution. Using direct dilution with 0.05 mg/mL F3-formulated DMTS the standard 
solutions of blank, 0.01, 0.02, 0.03, 0.04 mg/mL were prepared. The HPLC analysis was 
initiated by pipetting 600 µL solution out of the double diluted F3-formulated DMTS in 
EtOH to an HPLC vial. Then an aliquot of 400 µL of 0.1 mg/mL DMDS in acetonitrile 
was added to the vial. DMDS was used as the internal standard to avoid injection errors. 
The vial (Figure 17) was closed tightly with a screw-type cap, auto-vortexed for 10 seconds 
and mounted in the auto-sampler of the Dionex Ultimate 3000 (Thermo Scientific, 
Waltham, MA, USA) HPLC-UV instrument in Dr. Petrikovics’s lab. From the 1 mL 
sample mixture 40 µL was injected to the guard column (product number: KJ0-4282, 
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Phenomenex) connected to the 250 x 4.60 mm non-polar C-8 analytical column (product 
number: 00G-4250-EO, Phenomenex Luna, pore size of 100 Å, outer diameter 5 µm). The 
mobile phase consisting of 35% (v/v) water and 65% (v/v) acetonitrile was used with a 1 
mL/ min flow rate in isocratic mode. The absorbance of the eluate was monitored at 215 
nm by a UV detector. After the sequence run was completed, the chromatographic peaks 
were analyzed by the HPLC instrument software (Thermo Scientific Dionex Chromeleon 
7 version 7.2.0.3765). The peak area ratio of DMTS and DMDS was plotted against the 
DMTS concentration to obtain the calibration curve. 
Analysis of F3-formulated DMTS at each sampling point  
The internal standard of 0.1 mg/mL DMDS in ACN was freshly prepared from pure 
10 mg/mL DMDS (50 µL) diluted in ACN (4950 µL) solution. The stock 10 mg/mL DMDS 
solution was prepared by mixing 50 mg of pure DMDS in 5 mL of EtOH. Then three 
ampules from each temperature (Figure 15) were taken and left until they reach at room 
temperature. It was necessary to identify the proper dilution ratio for the analysis of the 
stored samples of the F3-formulated DMTS in HPLC-UV/Vis. First 50 µL aliquots from 
ampules were pipetted out and diluted with 4950 µL of EtOH (Figure 16a). From the first 
diluted sample, 50 µL were pipetted out and diluted with 4950 µL of EtOH to prepare the 
second diluted sample (Figure 16b). At the next step, diluted samples from the first and 
second dilution were mixed respectively with 600 µL and 400 µL of 0.1 mg/mL DMDS 
internal standard solution. The samples were analyzed at every sampling point during the 
study period. Samples were analyzed by the same instrumental method that was used when 
preparing the calibration curve.  Since the single dilution showed a significantly higher 
peak area for DMTS and DMDS, the double dilution method was used for the later analysis. 
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Similarly, peak area ratios were used for the data analysis and concentrations were 
determined using the best fit regression equation obtained from the calibration curve.  
 





Figure 16. a) First Dilution of the F3-formulated DMTS. b) Second Dilution of the F3-
formulated DMTS.  
 
 
Figure 17. Instrument Friendly Samples with the Internal Standard of 0.1 mg/mL of 
DMDS in Acetonitrile (ACN) added.  





Analysis of Long-Term Storage Stability Samples in GC-MS  
Since, the samples stored at 37 ºC showed a degradation, they were analyzed using 
GC-MS method. The F3-formulated DMTS was high concentrated, therefore solid phase 
microextraction (SPME) method was used. The F3-formulated DMTS of 37 ºC stored 
samples from long-term storage stability study were transferred to vials directly. The 
sample was exposed to SPME fiber assembly (100 µm polydimethylsiloxane fused 
silica/SS) for 30 seconds. It was analyzed in GC-MS with inlet temperature of 180 ºC. The 
oven temperature was changed to 50 ºC to 280 ºC with a ramp of 40 ºC/min. The MS 
spectra was analyzed using MSD ChemStation Data Analysis Application. The same 
scenario was followed in triplicate. 
 
PART 2 
Preparation of Reactants for DMTS Oxidation with mCPBA  
As reported previously48, required amounts of DMTS and mCPBA were prepared 
in 99% (v/v) CH2Cl2. Several alterations were added to the protocol to meet the final 
requirements and the optimized method is described below.  
Preparation of carbonate buffer solution with a pH of 9.9  
Concentration of 0.100 M carbonate buffer solution was prepared mixing 0.530 g 
of sodium carbonate and 0.420 g of sodium bicarbonate in 50 mL of HPLC grade water. 
The final pH was measured using pH meter.  
Preparation of DMTS solution  
DMTS (2.016 g) was dissolved in 8 mL of CH2Cl2 and kept between temperatures 
of -5° and 0° C.  
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Preparation of mCPBA solution  
mCPBA (3.040 g) was dissolved in 32 mL of CH2Cl2 and kept between 
temperatures of -5° and 0° C.  
Preparation of mobile phase for TLC plate analysis 
C6H14 (2.1 mL of 99.5+% (v/v)) was mixed with 900 µL of 99.5+% (v/v) EtOAc 
and placed in a sealed glass vial. 
C6H14 (3 mL of 99.5+% (v/v)) was placed in a sealed glass vial. 
Preparation of TLC plates for the sample analysis  
The TLC plates (200mm x 200mm pH=5 MF254 aluminum back plate) were 
prepared with 6.5 cm length, 2.5 cm width and 2 limits were marked on the plate for starting 
solvent front (1 cm from bottom) and ending solvent front (0.5 cm from top). Two samples 
were placed on one plate and 2 plates were used for 3 parallels and for control.  
 
 





P1 P2 P3 C 
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Preparation of the reaction mixture for the seven day analysis 
The prepared mCPBA (8 mL) solution was slowly added to the DMTS (32 mL) 
solution in the reaction flask between -5° and 0° C. It was stirred for 30 minutes using a 
glass rod. Then the reaction mixture was kept at room temperature for an hour. 1200 µL of 
reaction mixture was aliquoted to each HPLC vial and kept at room temperature for further 
analysis. 21 vials were prepared to yield 3 parallels for each consecutive day.   
 
Preparation of Day 0 to Day 7 samples for HPLC and GC-MS analysis  
Sample of the reaction mixture (500 µL) was vortexed and extracted with 500 µL 
carbonate buffer solution in an eppendorf vial. The organic layer was saved. The sample 
from organic layer (50 µL) was diluted with 450 µL ethanol and was autovortexed for 5 
minutes. Sample solution (70 µL) was mixed with 630 µL of ethanol and hand vortexed 
for 30 seconds. This sample was used for the HPLC, TLC and the GC-MS analysis. No 
internal standard was added during the preparation of the samples for HPLC UV-Vis, TLC 
and GC-MS analysis.    
 
Analysis of Day 0 to Day 7 samples on TLC plates  
Sample (5 µL) was placed on the prepared TLC plate 0.5 cm above the running 
solvent level. Two drops were placed on one plate and the solvent was let to evaporate. A 
thin layer of mobile phase (hexane) was poured into the base of a small beaker. The spotted 
TLC plates were placed into the beaker. The whole setup was covered with a larger beaker 
to let the system to saturate with solvent. The TLC plate was removed from the apparatus 
just before the solvent front reached the end of the plate.  
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The separation of components on the TLC plates were observed under law 
wavelength (254 nm) UV-Light. The observed component spots were marked as polar and 
non-polar for further analysis.  
 
Preparation of Reactants for DMTS Oxidation with H2O2   
Preparation of DMTS solution in 15% poly 80  
Poly 80 (1.5 g) was added to a 10 ml volumetric flask, filled up with distilled water 
and vortexed for 5 min to prepare 15% (m/v) poly 80 solution. DMTS (50 mg/mL) was 
prepared in 15% (m/v) poly 80 solution.  
Preparation of 3% H2O2 solution  
H2O2 (800 µL) was added to 7200 µL of distilled water and vortexed.  
Preparation of the reaction mixture for DMTS Oxidation with H2O2  
H2O2-3% (v/v) (500 µL) was added to 500 µL 50 mg/ml DMTS in 15% (m/v) poly 
80. The reaction mixture was separated into 15 vials and kept for 5-days at room 
temperature.  
 
Preparation of the Samples for GC-MS Analysis, Separated from TLC Plates    
The identified TLC sample spots were cut into tiny pieces and placed in an 
eppendorf vial. ACN or acetone (150 µL) was added and the vial was auto-vortexed for 2 
minutes. Then the eppendorf vial was centrifuged at 14000 g for 5 minutes. 50 μL of the 




Preparation of F3-Formulated DMTS and Pure DMTS for Oxidation 
Comparison Study.  
The DMTS (0.063 g) was dissolved in 5 mL of CH2Cl2 to prepare 0.1 M pure 
DMTS solution. F3-formulated DMTS (315 μL) was dissolved in 685 μL of CH2Cl2 and 
100 μL of it was diluted with 900 μL of CH2Cl2 to prepare 0.1 M F3-formulated DMTS. 
The mCPBA (0.086 g) was dissolved in 5 mL of CH2Cl2 to prepare 0.1 M mCPBA solution. 
The prepared solutions were kept between -5 and 0 ºC until the reactions began. 
400 μL of 0.1 M pure DMTS and 400 μL 0.1 mCPBA were reacted in a HPLC vial 
and similarly 400 μL of 0.1 M F3-formulated DMTS and 400 μL 0.1 mCPBA were reacted 
in a separate HPLC vial. These were let to react for one week and analyzed in HPLC using 





RESULTS AND DISCUSSION 
PART 1 
Storage of the Formulated DMTS 
Previously, three methods of storage were studied for their stability. Those studied 
were: a) single crimp-seal method, b) double crimp-seal method and c) hermetically fire-
sealed glass ampule method. Storage sealing method was compaired for F2-formulated 
DMTS, and the hermetically fire-sealed glass ampules proved to be the best storage 
method. With the single crimp-seal method, the F2-formulated DMTS was stable for only 
two days and after one-week only 40% (M/M) of the original DMTS was detected. With 
the double crimp-seal method after two weeks, 65% (M/M) of the original DMTS amount 
was detected. However, the hermetically fire-sealed glass ampule stored samples showed 
good stability: the Poly80 DMTS solution was stable for a month with 100% (M/M) 
recovery.28 Therefore, the ampule method was chosen to study the long-term storage 
stability of the F3-formulated DMTS. 
 
Determination of Sample Condition Before and After Ampule Sealing 
Here, 1900-2000 ºC flame was used to seal the ampules, which can cause damage 
by thermally reacting with the samples inside the ampules. It was important to check if 
there was any change in the DMTS content during the ampule sealing. Therefore, three 
samples were analyzed before and after ampule sealing using the previously set 
instrumental method. Results showed that the flame had no effect on the formulated DMTS 




Figure 19. Concentration Comparison of F3-formulated DMTS Before and After Sealing 
of Glass Ampules. Data are presented as mean ± S.D., n = 3.  
 
The specific wavelength used in the HPLC-UV/Vis for DMTS determination was 
215 nm. The intensity of DMTS and DMDS have gone up at lower wavelengths. The 
selected wavelength was used because the solvent cut-off wavelength in HPLC for 
acetonitrile is 200 nm. The following are the UV-Vis spectra for DMTS and DMDS (Figure 
20). The storage temperatures, which were 4 ºC in refrigerator, 22 ºC in cupboard and  
37 ºC in oven, did not show any significant fluctuation at the sampling point throughout 
study period. 
       


























































Figure 21. HPLC Chromatogram of the F3-Formulated DMTS (1:15000 diluted) on  
Day 0. The internal standard was DMDS (0.1 mg/mL in ACN). 
 
 
In the spectrum, the retention time for DMTS was 8.1 min and for the internal 
standard (IS) DMDS 6.0 min (Figure 21). The peak areas of DMTS and DMDS were used 
to calculate the peak area ratios, with following formula (Equation 1). 
𝑃𝑒𝑎𝑘 𝐴𝑟𝑒𝑎 𝑅𝑎𝑡𝑖𝑜 =
𝑃𝑒𝑎𝑘 𝐴𝑟𝑒𝑎 𝑜𝑓 𝐷𝑀𝑇𝑆 (𝑚𝐴𝑈∗𝑚𝑖𝑛)
𝑃𝑒𝑎𝑘 𝐴𝑟𝑒𝑎 𝑜𝑓𝐷𝑀𝐷𝑆 (𝑚𝐴𝑈∗𝑚𝑖𝑛)
  
Equation 1: Formula for the Calculation of Peak Area Ratio. 
 
All the sampling points were analyzed with the aid of a calibration curve which 
gave good linearity with increasing concentration (Figure 22). The calibration curve 
showed the equation of 𝑦 = 102.23𝑥 − 0.0433 with the R2 = 0.9991.  
The limit of detection (LOD) and limit of quantification (LOQ) were determined 
for the method. 
LOD                    = Yblank + 3s   = 0.0238 + (3 × 6.98*10
-5)   = 0.0240 
Concentration LOD = 3s/ m        = (3 × 6.98*10-5)/102.23      = 2.05 ng/mL 
LOQ                    = Yblank + 10s  = 0.0238 + (10 × 6.98*10
-5) = 0.0245 






Day 0, Before storage 
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Where Yblank is the mean of the blank signal, s is the standard deviation of the signal 
for the lowest analyzed concentration and m is the gradient of the calibration curve. 




  where 𝑥𝑚 is the mean of the repeats, 𝑥𝑖 is the value of an 




Figure 22. Calibration Curve Prepared for the Determination of the DMTS Concentration 
of the Stability Samples (400 mg/mL DMTS in the F3-Formulation). Data are presented 
as mean ± S.D., n=5. Some error bars are not visible as the S.D. is low. 
 
The intra- and inter-day precisions and accuracies were estimated using 
concentrations of DMTS in F3-formulation (Table 2). The intra- and inter-day precisions 
varied from 0.19 to 2.34 CV%, while the intra- and inter-day accuracies varied from -2.37 
to 1.18 %. According to the FDA guidelines, both precision and accuracy should fall within 
a range of ±15%.49 Following equations were used to calculated precision and accuracy 
(Equaiton 2, Equation 3). 





























Concentration of DMTS (mg/mL)
32 
 
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =  
𝑆𝑡𝑑. 𝐷𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑡ℎ𝑒 𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
𝑀𝑒𝑎𝑛 𝑜𝑓 𝑡ℎ𝑒 𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
× 100% 
Equation 2: Formula for Calculation of Precision. 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 = (
𝑆𝑡𝑑. 𝐷𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑡ℎ𝑒 𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
𝑀𝑒𝑎𝑛 𝑜𝑓 𝑡ℎ𝑒 𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑑 𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛
× 100%) − 100 
Equation 3: Formula for Calculation of Accuracy. 
Table 2. 















Intra-day (n=5)     
10.0 9.815 0.19 0.20 -1.85 
20.0 19.62 2.13 1.09 -1.89 
30.0 29.26 6.90 2.36 -2.46 
40.0 40.05 3.14 0.78 0.13 
50.0 50.58 6.24 1.23 1.17 
Inter-day (nday1 
= 5, nday2 = 5) 
    
10.0 10.12 0.93 0.92 1.19 
20.0 20.08 3.09 1.54 0.40 
30.0 30.10 4.29 1.42 0.35 
40.0 40.00 6.37 1.59 0.01 
50.0 49.88 1.50 0.30 -0.24 
 
Determination of the Long-term Storage Stability of the F3-Formulated DMTS 
The objective of this study was to determine the long-term storage stability of the 
F3-formulated DMTS contained in hermetically fire-sealed glass ampules. Since the 
previous studies showed significant protection for the F2-formulated DMTS in 
hermetically fire-sealed glass ampules, the same sealing approach was used for the current 
study. Samples were allowed to come to room temperature prior to analysis (since the 
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samples stored at different temperatures). The necks of the glass ampules were broken with 
gloved hand with proper care. All the sampling points were analyzed after 15000 times 
dilution in HPLC-UV/Vis and the concentration of each sample was calculated using the 
calibration curve (Figure 22). The % (M/M) DMTS was calculated using the following 
equation (Equation 2).  
% 𝐷𝑀𝑇𝑆 =
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑡ℎ𝑒 𝐷𝑀𝑇𝑆 𝑎𝑡 𝑆𝑎𝑚𝑝𝑙𝑖𝑛𝑔 𝑃𝑜𝑖𝑛𝑡
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝐷𝑀𝑇𝑆 𝑏𝑒𝑓𝑜𝑟𝑒 𝑆𝑡𝑜𝑟𝑎𝑔𝑒 (𝑇𝑖𝑚𝑒 0)
× 100% 
Equation 4: Formula for the Calculation of Percent DMTS. 
 
The results showed that there was no measurable loss of DMTS over the one-year 
period of the study for the samples stored at 4, 22 ºC. The samples stored at 37 ºC showed 
good stability for five months (Figure 23). The data used to calculate the % DMTS during 
the study are included in the appendix B. Some of the replicate data from the data points 
were removed due to dilution errors.  
 
 
Figure 23. One Year Stability of the DMTS in the F3-Formulation. Data are presented as 














4 °C 22 °C 37 °C
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 Since the concentration change in the sixth-month sample at 37 ºC was significant, 
the HPLC spectra (Figure 25) were examined for any differences in the peak heights and 
peak areas. The solutions were observed for any color and physical changes. It was also 
significant that the 37 °C stored sample changed its color: the light yellow color has 
changed to dark brown color. The solution was transparent; no precipitation was observed 
(Figure 24). 
Figure 24. Color Change of the F3-Formulated DMTS stored at 37 ºC in an Ampule at 
Month 7 Compared to the Samples Stored at 4 and 22 ºC.   
 
All the spectra were compared from Month 0 to Month 12 at 37 ºC to identify the 






























































































Figure 25. Chromatograms of the F3-Formulated DMTS Stored at 37 ºC.  A-L are from 
time 0 to year 1. Mobile phase used 65:35 = ACN:H2O 
 
 
Observations of the chromatogram from month 6 showed the development of a new 
peak at 10.9 min retention time and the chromatogram from month 8 showed development 
of another peak at 15.1 min. These peaks were labelled as unknown 1 and unknown 2 until 






















DMDS: 6.0 min 










DMDS as a New Peak 
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HPLC-UV/Vis without IS DMDS and the chromatogram showed a peak at 6.0 min 
suggesting that degradation of DMTS helped to develop DMDS as one of the degradation 
product (Figure 26). Product DMDS peak labeled as New Peak 3. The height and area of 
DMTS peak have gone down significantly while the peak area and the height have gone 
up for DMDS (product), Unknown 1 and Unknown 2. With the occurrence of new the 
peaks the formulation got darker. For further clarification, chromatograms obtained from 
samples at 37 ºC, those were plotted in a overlay graph (Figure 27). The board peak 
observed in the chromatograms could not be identified as one of the product since in has 
shown in all the three different temperatures except for the very first injection. It was 




Figure 26. Comparison of Chromatograms of the 37 ºC Stored Month 9 F3-Formulated 
DMTS sample with and without internal standard. Mobile phase used 65:35 = ACN:H2O 
 
Month 9: 37 ºC – Without DMDS as IS 





















Figure 27. HPLC Chromatograms of the Samples of F3-Formulated DMTS up to Month 
12 Stored at 37 ºC. Mobile phase used 65:35 = ACN:H2O 
 
This observation lead to the examination of the color changes in other samples 
stored at 22 ºC temperature. There was no color change in the samples stored at 22 ºC. The 
color change of the samples were examined by nacked eye. The chromatograms were 
inspected for occurance of new peaks at same retention times. The chromatograms obtained 




























































































Figure 28. Chromatogram Comparison of the F3-Formulated DMTS Stored at 22 ºC 
from Time 0 to Year 1. Mobile phase used 65:35 = ACN:H2O 
 
 
The chromatograms obtained from samples stored at 22 ºC showed no observable 
new peaks throughout the period of analysis suggeting that the samples are stable at room 
temperature. The chromatograms from the samples stored at 4 ºC and 22 ºC were also 























Figure 29. Chromatograms of the F3-Formulated DMTS up to Month 12 Samples Stored 
at 4 ºC and 22. Mobile phase used 65:35 = ACN:H2O. 
 
 
According to the chromatograms obtained from samples stored at 4 and 22 ºC, there 
were no new peaks. These observations confirm the long-term stability of F3-formulated 
DMTS in samples stored at 4 and 22 ºC conditions. The solvent run time was changed at 









Identification of the Degradation Products.  
Observation of new peaks led to the investigation on degradation products. A GC-
MS SPME method was used in this study which can provide good filtering mechanism 
which ensures, only volatile components are injected to the GC-MS, because the polymer 
surfactants are very nonvolatile and would risk plugging the analytical column. It needed 
to use high split ratio due to the high concentration of these samples even after degradation. 
After several set of preliminary experiments, the optimum split ratio of 600:1 was selected. 
According to the MS library, three major components were identified with 90% top hit 
match for each of the compound. There was only one significant peak for the samples at 
low temperatures (Figure 30). The identified products are DMDS, DMTS and DM4S with 
the retention times of 2.20 min, 3.05 min and 3.90 min, respectively (Figure 31). There 
was no degradation at the injection port according to the GC parameters used. This 
confirms the occurrence of identified products at higher temperature stored samples. 
 
 
Figure 30. GC Chromatograms of the F3-Formulated DMTS Stored at 22 ºC at Month 11. 
600:1 split ratio was used in the SPME method (30 s) and He was used as the carrier gas. 
 







Figure 31. GC Chromatograms of the F3-Formulated DMTS Stored at 37 ºC at Month 11. 
600:1 split ratio was used in the SPME method (30 s) and He was used as the carrier gas. 
 
PART 2 
Investigation on the Oxidation Products of DMTS 
F3-formulated DMTS was stored in hermetically fire-sealed glass ampules. During 
storage a small volume of air was contained in the ampule which could lead for oxidation 
of DMTS. Therefore, to investigate the possible products of DMTS after oxidation, a 
second project was set up. 
Preparation of DMTS and mCPBA was done in CH2Cl2, in which they had 
reasonable solubility. The incubation period was elongated for one week, because two 
hours after the initiation of the reaction did not produce the expected amount of product as 
mentioned in the reference.48 
The prepared solutions of the oxidation reaction were analyzed in HPLC and the 
following chromatograms were obtained (Figure 32). The pH of the carbonate buffere 
solution was 9.98 after preparation. This was the suitable pH for removal of biproducts 
from the reaction mixture such as 3-chlorobenzoic acid (3CBA). On day 0, which is before 
the reaction began, the DMTS solution prepared with CH2Cl2 gave the first chromatogram 
DMDS: 2.20 min 
DMTS: 3.05 min 
DM4S: 3.90 min 




shown in the figure (Figure 32). There was a higher amount of DMTS in the reactant giving 
0.01 mol/L concentration. DMDS did not use as an internal standard since it appeared as 
one of the degradation product in long-term storage stability study. Starting from the day 
1 the reaction mixture was analyzed in three solution parallels per day. All the 
chromatograms were obtained from the first parallel solution from each day. 
According to the chromatograms obtained from each day during the reaction time 
of the samples in HPLC-UV/Vis analysis, six significant peaks were able to observe and 
three of them were changing with the reaction time. The observed peaks were labelled as 
follows with their retention times. 3CBA (2.2 min), New peak 4 (3.7 min), DMTS peak 
(10.0 min), New peak 1 (13.7 min) and New peak 2 (20.0 min) in order (Figure 32). The 




Figure 32. Chromatograms of the HPLC-UV/Vis Analyzed Samples of DMTS Reaction 
Mixture with mCPBA. The X axis is retention time and Y axis is mAU*min. Mobile phase 
was ACN:H2O = 60:40. 
 
Therefore, there is a huge difference in peak areas of DMTS in Day 0 sample and 
rest of the samples. 
DMTS: 
10.0 min 
New Peak 1: 
13.7 min 
New Peak 2: 
20.0 min 










Identification of the Oxidized Products of the Reaction DMTS with mCPBA 
Identification of above observed peaks were carried out with GC-MS and HPLC –
UV/Vis. Industrially available samples were used for confirmation. With the help of GC-
MS results 4 components were able to identified. The identified components are DMTS at 
3.05 min, SMMTS at 3.37 min DM4S at 3.93 min and 3CBA at 4.25 min (Figure 33). The 
HPLC chromatogram analysis suggested that the peaks observed at 2.2 min is 3-
chlorobenzoic acid, peak at 5.0 min is CH2Cl2 (Figure 34). The broad peak were not seen 
earlier since 2.60 min solvent delay was used and were not analyzed. 
 
 
Figure 33. Chromatogram of the GC-MS Analyzed Sample of the DMTS Oxidation 
Reaction Mixture with mCPBA at Day 7.  
 
Figure 34. HPLC-UV/Vis Chromatogram of Analyzed Sample of the Commercially 
















The oxidation reaction of DMTS with mCPBA is fast. Since the S-methyl 
methanethiosulfonate is an intermediate product of the reaction its amount was decreased 
with time. However, the DM4S and product 2 showed increase peak area with time. It 
seems that the continuous reaction favors the production of more DM4S and product 2 in 
the long run. 
The increase of the observed peaks were plotted against the reaction time and the 
following graphs were obtained. The statistical analysis of peak areas were conducted over 
the products which DM4S, DM5S and reactant DMTS (Figure 35). Similarly, the 
development of peak areas of DM4S and DM5S was clearly shown in the stacked graph of 
chromatograms. Decrease of peak height and areas of SMMTS may due to precipitation 
observed during the study period (Figure 32). 
DMDS was not used as an internal standard for the quantitative analysis, after we 
realized that it was also one of the degradation products. After this realization, peak areas 
were reported either as absolute peak areas or as relative peak ares (ratio of the peak area 
to the initial DMTS peak area) as shown in Equation 3. It is of significance that we were 
not able to identify DMDS as one of the oxidation reaction product. We suspected that the 
oxidation of DMTS may produce DMDS similar to stability study results. But according 
to the results it might be the DMDS that has oxidized to SMMTS by mCPBA by attaching 
two oxygen atoms to one of the sulfur atoms. 
 
𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑃𝑒𝑎𝑘 𝐴𝑟𝑒𝑎 =
𝐴𝑟𝑒𝑎 𝑜𝑓 𝑡ℎ𝑒 𝐶𝑜𝑚𝑝𝑜𝑛𝑒𝑛𝑡 𝑖𝑛 𝑆𝑝𝑒𝑐𝑡𝑟𝑢𝑚 𝑤𝑖𝑡ℎ 𝑇𝑖𝑚𝑒
𝐴𝑟𝑒𝑎 𝑜𝑓 𝑡ℎ𝑒 𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝐷𝑀𝑇𝑆 𝑃𝑒𝑎𝑘 𝑖𝑛 𝑆𝑝𝑒𝑐𝑡𝑟𝑢𝑚 
× 100% 




 The initial relative peak area has shown as 100% (m/m), and the Y axis had to be 
cut down to show the rest of the components. 
    
Figure 35. Growing Concentration of Products of DM4S and DM5S; and Reduction in 
the Concentration of DMTS during its Reaction with mCPBA.  
 
 
TLC Analysis of Reaction mixture of DMTS with mCPBA  
DMTS and other polysulfide molecules are linear and they are non-polar. 
Therefore, they elute from the reverse phase HPLC column in the order of increasing non-
polar characteristic. The oxidized products contain oxygen which makes the molecule 
polar, therefore they elute from the column early, almost with the solvent phase. The 
reaction mixture was separated in TLC using their polar characteristics. The non-polar 
solvent, hexane used as the mobile phase and polar silica TLC plate used as the stationary 
phase.  
The separated reaction mixture on F254-impregnated TLC plate is significantly 
visible under UV-light (Figure 36). The marked polar spot was extracted using ACN and 
it was analyzed in GC-MS for identification of components. GC chromatogram confirmed 
the presence of SMMTS and mCBA in the polar spot (Figure 37) with other several other 
unidentified compounds. Also there are some components which could not identified by 
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50 
 
analyzed in GC-MS. According to the MS library it confirmed the observation of DMTS 
and DM4S in the non-polar spot as components (Figure 38). 
      
 









Figure 38. GC-MS Chromatogram of the Analyzed Non-polar Spot.  
 
 
Identification of the Oxidized Products of the Reaction DMTS with H2O2 
GC-MS analysis were not carried out for the reaction with H2O2, because water used 
as a solvent. Application of water may damage the GC column due to ability of dissolving 
many salts. Since the amounts of products from the H2O2 used oxidation reaction were less, 














and qualitative analysis were carried-out for this reaction with H2O2 only in HPLC-UV/Vis. 
According to the HPLC chromatogram analysis, DM4S and DM5S have identified as the 
significant products (Figure 39), that absorb at the detection wavelength.  
 
 
Figure 39. HPLC Spectrum of the Reaction of DMTS and H2O2. Mobile phase was 
ACN:H2O = 60:40. 
 
A similar method was used to quantify the products of the H2O2 reaction as the 
earlier mCPBA reaction (Figure 40). The amounts of products of the H2O2 reaction mixture 
was significantly lower than that of the mCPBA reaction (Figure 35). All the products 
obtained were less than remaining amount of DMTS after the reaction. 
 
 
Figure 40. Increase of Products of DM4S and DM5S; and the Decrease of the Reactant 

































HPLC-UV/Vis Spectral Comparison of the Reactions of DMTS with mCPBA or 
H2O2 
There is no significant data about development of SMMTS in this reaction mixture. 




Figure 41. HPLC Spectrum Comparison for Reaction Mixtures of mCPBA and H2O2 
with DMTS. Mobile phase was ACN:H2O = 60:40. 
 
 
Comparison between HPLC Methods Used in the Storage Stability Study and the 
Oxidation Study 
Stability Study Sample Analysis with Oxidation Study Method  
One-year-old stability study samples were analyzed using oxidation study 
instrumentation method which uses 60% (v/v) ACN and 40% (v/v) HPLC grade water. 

















Reaction Mixture - Day 5 
(DMTS + mCPBA) 










the peak retention times in each of the spectra are due to change in the solvent ratio used 
in the HPLC methods. According to the stability instrument method the components have 





Figure 42. HPLC Spectrums of Stability Study Samples at 37 ºC after One Year. Samples 




Analysis and Comparison of the Oxidation Products of DMTS and the F3-
Formulated DMTS.  
It is necessary to reconcile the retention times for peaks arising from the same 
compounds in the two different HPLC methods that were employed. Therefore, the 
samples prepared for oxidation were analyzed using HPLC method used in stability study 
Stability Instrumentation Method 
65% ACN:35% H2O 
Oxidation Instrumentation Method 



















to see the change in retention time of each component peak. At the same time, F3-
formulated DMTS and pure DMTS were reacted with mCPBA to understand the strength 
of the formulation during oxidation reaction. Similar concentrations were prepared for the 
analysis for comparison purposes. After a one-week reaction period, samples were 
analyzed by HPLC-UV/Vis and similar products were observed. Also, they have shown 
similar retention times for the components as long-term storage stability study. Same 
number of moles (0.0005 mol) of pure DMTS, F3-formulated DMTS and mCPBA were 
used in this experiment to understand the effect of F3-formulation during the reaction with 
mCPBA. The stoichiometry of the reaction between DMTS and mCPBA did not 
investigate during this study since it has shown set of reaction during the oxidation of 
DMTS. In the reaction with pure DMTS, slightly higher amount of DMTS had been reacted 
and higher amount of DM4S, DM5S have been produced than F3-formulated DMTS 
reaction. Since the reaction mixture was analyzed after one week the amount of SMMTS 
was very low and were not used in comparison. In contrast, in the reaction with F3-
formulated DMTS, less amount of initial DMTS has reacted with mCPBA compared to 
pure DMTS reaction, and lesser amounts of DM4S, DM5S and no SMMTS were identified. 
There might SMMTS present in the F3-formulated DMTS reaction and acted similar to 
pure DMTS reaction. This suggests that F3-formulation provides certain level of protection 
over DMTS, controlling the reaction availabilities of DMTS with mCPBA (Figure 43). The 
peak areas were analyzed comparative to the initial amount of DMTS before each reactions 






Figure 43. HPLC-UV/Vis Spectra of the Two Reaction Mixtures with mCPBA. Mobile 




Figure 44. Product Amount Comparison of mCPBA Reactions with Pure DMTS and F3-















































Long-Term Storage Stability of the F3-Formulated DMTS 
F3-formulated DMTS showed high long-term storage stability within a one-year 
period. The samples stored at 4 and 22 ºC displayed 100% (M/M) stability over a 12-month 
study. However, the samples stored at 37 ºC showed 100% (M/M) stability only over a 5-
month period and gradually decreased to 30% (M/M) of initial concentration at the end of 
the study. The F3-formulation itself provided better protection for DMTS by lowering 
reaction rate even in the presence of strong oxidizing agents. Therefore, it can be concluded 
that the hermetically fire-sealed glass ampules can provide significantly better protection 
for F3-formulated DMTS in the long run. 
 
Investigation on the Degradation Products of the F3-Formulated DMTS 
Due to the degradation of F3-formulated DMTS there were several degradation 
products observed. The three major identified degradation products are DMDS, DM4S and 
DM5S which have relative retention times of 6.0 min, 10.9 min and 15.1 min respectively. 
Dimethyl polysulfides were recognized as the products of the disproportionation reaction 
of DMTS at high temperatures. We can conclude that in our experiments DMDS, DM4S 





Identification of the Oxidized Products of DMTS in the Presence of Strong 
Oxidizing Agents 
Reaction with mCPBA.  
The oxidation reaction with mCPBA yielded DM4S, DM5S and SMMTS, but no 
DMDS as a product.  
Reaction with H2O2.  
The oxidation reaction with H2O2 showed the formation of DM4S and DM5S, but 
there was no observation of SMMTS. This may be due to the lower oxidation strength of 
the 3% H2O2. 
 
Comparison of the Products of the Long-term Storage Stability Study and the 
Oxidation Study  
The products identified from the long-term storage stability study and the oxidation 
reaction showed an overlap: both DM4S and DM5S were found in both. Additionally, 
DMDS was observed as a product during the degradation of DMTS but did not appear 
during the oxidation study. The results observed from stability study matched with the 
literature for disproportionation. The production of SMMTS and the absence of DMDS in 
oxidation with mCPBA can be mentioned as the difference between the two studies. The 
results of the TLC analysis suggested the feasibility of preparative chromatography for the 
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CN-: cyanide anion 
TS: thiosulfate 
Rh: Rhodanese 
SD: sulfur donor 
DMS: dimethyl sulfide 
DMTS: dimethyl trisulfide 
DMDS: dimethyl disulfide 
DM4S: dimethyl tetrasulfide 
DM5S: dimethyl pentasulfide 
SMMTS: S-methyl methanethiosulfonate 
mCPBA: meta-chloroperbenzoic acid 
mCBA/3CBA: meta-chlorobenzoic acid 
poly 80: polyoxyethylenesorbitan monooleate 
span 80: sorbitan monoenolate 
HPLC: high pressure liquid chromatography 
GC-MS: gas chromatography mass spectrometry 
TLC: thin layer chromatography 
IM: intramuscular  
IV: intravenous 
S.D.: sample standard deviation 
(m/m): mass/mass ratio 




Data and the calculations used to obtain the Figure 23. 
 Day 0 
  DMDS DMTS Ratio Avg. Rat. % 
Avg. 
% % RSD 
4 




12.334 39.34 3.189557 97.32417 
12.756 42.22 3.309815 100.9936 
22 




12.334 39.34 3.189557 97.32417 
12.756 42.22 3.309815 100.9936 
37 




12.334 39.34 3.189557 97.32417 
12.756 42.22 3.309815 100.9936 
 
Day 6 
DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




14.522 46.985 3.235436 98.72408 
14.417 47.3 3.280849 100.1098 




14.414 46.396 3.218815 98.21692 
14.498 46.737 3.223686 98.36555 




14.379 46.098 3.205925 97.82361 
14.358 46.767 3.257209 99.38844 
 
Week 1 
DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




14.455 45.227 3.128814 95.47067 
14.018 47.96 3.421315 104.3959 




13.691 45.721 3.339493 101.8992 
14.491 47.224 3.25885 99.43854 




14.313 46.711 3.263537 99.58153 






DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




14.084 48.404 3.436808 104.8686 
14.159 47.036 3.321986 101.365 




14.041 47.625 3.391852 103.4969 
13.991 48.339 3.455007 105.4239 




14.171 46.314 3.268224 99.72455 
14.143 46.451 3.284381 100.2176 
 
Week 3 
DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




13.253 45.229 3.412737 104.1341 
13.911 44.788 3.21961 98.24119 




13.972 44.867 3.211208 97.98481 
13.83 47.509 3.435213 104.82 




13.924 45.931 3.298693 100.6543 
13.82 44.815 3.242764 98.94769 
 
Month 1 
DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




14.152 45.061 3.184073 97.15682 
14.336 46.088 3.214844 98.09575 




14.056 43.889 3.122439 95.27616 
14.078 44.572 3.166075 96.60764 




13.869 42.512 3.065253 93.53124 







DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




13.385 41.697 3.115204 95.05539 
13.625 45.855 3.365505 102.6929 




13.747 44.346 3.225867 98.43212 
13.897 46.055 3.314025 101.1221 




13.872 44.745 3.225562 98.4228 
13.896 46.744 3.363846 102.6423 
 
Month 3 
DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




14.13 45.955 3.2523 99.23866 
14.169 45.385 3.203119 97.738 




13.036 43.409 3.329932 101.6075 
13.454 41.828 3.108964 94.86499 




13.375 47.245 3.532336 107.7835 
13.516 44.788 3.313702 101.1123 
 
Month 4 
DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




13.13 42.037 3.201599 97.69162 
13.169 43.093 3.272306 99.84912 




13.036 42.758 3.279994 100.0837 
13.454 51.82 3.851643 117.5266 




13.375 41.961 3.137271 95.72874 







DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




13.087 42.987 3.28471 100.2276 
13.25 46.129 3.481434 106.2303 




12.919 40.44 3.130273 95.51521 
13.008 42.696 3.282288 100.1537 




12.289 39.963 3.251933 99.22745 
12.146 40.602 3.342829 102.001 
 
Month 6 
DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




13.258 45.35 3.420576 104.3733 
13.316 40.485 3.040327 92.77066 




13.367 44.805 3.351911 102.2781 
13.293 41.798 3.144362 95.9451 




13.831 41.865 3.026896 92.36083 
13.799 42.331 3.067686 93.60547 
 
Month 7 
DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




13.239 44.268 3.343757 102.0293 
13.233 43.657 3.299101 100.6667 




13.149 49.066 3.731539 113.8618 
13.203 40.672 3.080512 93.99683 




14.151 39.419 2.785598 84.99801 







DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




13.93 44.991 3.229792 98.55186 
13.934 44.867 3.219966 98.25203 




13.861 44.533 3.212827 98.03422 
13.892 44.375 3.194284 97.46841 




14.551 20.379 1.400522 42.73467 
14.56 20.313 1.395124 42.56994 
 
Month 9 
DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




12.042 40.301 3.346703 102.1192 
12.98 42.265 3.256163 99.35655 




12.146 40.987 3.374527 102.9682 
12.932 42.357 3.275363 99.94241 




14.13 19.648 1.390517 42.42936 
14.515 19.702 1.357354 41.41747 
 
Month 11 
DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




13.713 45.36 3.30781 100.9325 
13.793 47.307 3.429783 104.6543 




13.858 45.535 3.285828 100.2617 
13.761 42.551 3.092144 94.35178 




13.912 17.958 1.290828 39.38753 







DMDS DMTS Ratio Avg. Rat. % Avg. % % RSD 




13.713 45.296 3.303143 100.7901 
13.793 46.942 3.403321 103.8468 




13.858 43.929 3.169938 96.72552 
13.761 43.315 3.147664 96.04586 




13.912 16.836 1.210178 36.92663 
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